Medco Holdings's Days Sales Outstanding for the
three
months ended in Mar. 2026 was 175169.58.
Medco Holdings's Days Inventory for the
three
months ended in Mar. 2026 was 0.
Medco Holdings's Days Payable for the
three
months ended in Mar. 2026 was 0.
Therefore, Medco Holdings's Cash Conversion Cycle (CCC) for the
three
months ended in Mar. 2026 was 175,169.58.
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
Medco Holdings Cash Conversion Cycle Related Terms
Medco Holdings Cash Conversion Cycle Historical Data
* Premium members only.
The historical data trend for Medco Holdings's Cash Conversion Cycle can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PHS:MED vs BLK, BX, KKR: Cash Conversion Cycle Comparison
For the Asset Management subindustry, Medco Holdings's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medco Holdings Cash Conversion Cycle vs Asset Management Industry
For the Asset Management industry and Financial Services sector, Medco Holdings's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where Medco Holdings's Cash Conversion Cycle falls into.
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
Medco Holdings's Cash Conversion Cycle for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Cash Conversion Cycle of 175,169.58 mean?
Medco Holdings (PHS:MED) has a Cash Conversion Cycle of 175,169.58 as of Mar. 2026. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Medco Holdings and its competitors.
Is Medco Holdings' Cash Conversion Cycle too high?
Medco Holdings' current Cash Conversion Cycle is 175,169.58. The Asset Management industry median Cash Conversion Cycle is 4.55. Medco Holdings' value of 175,169.58 is 3849780.9% above this industry median.
How does Medco Holdings' Cash Conversion Cycle compare to BLK and BX?
Medco Holdings' Cash Conversion Cycle of 175,169.58 can be compared against companies in the Asset Management industry. The industry median Cash Conversion Cycle is 4.55. Medco Holdings' value of 175,169.58 is 3849780.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for an Asset Management company?
The median Cash Conversion Cycle among Asset Management companies is 4.55, based on 603 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medco Holdings's current Cash Conversion Cycle of 175,169.58 is 3849780.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Medco Holdings and its competitors. For the Asset Management industry, the median Cash Conversion Cycle is 4.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medco Holdings's current Cash Conversion Cycle is 175,169.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medco Holdings stock overvalued right now?
Medco Holdings (PHS:MED) has a current Cash Conversion Cycle of 175,169.58. The current Cash Conversion Cycle is 175,169.58 and 3849780.9% above the Asset Management industry median of 4.55. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Medco Holdings (PHS:MED), the current Cash Conversion Cycle is 175,169.58 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medco Holdings Inc is an investment holding company. The company's investment portfolio is composed of holdings in a company involved in trade development (operation of exhibition halls and conference facilities).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PHS:MED has been successfully added to your 